Kyung Dong Pharmaceutical Co., Ltd.

A011040

KR7011040003

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
6,480 ^KRW	-0.15%		+1.25%	-1.97%

May. 03	Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	CI
May. 03	Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	CI

Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.

September 15, 2022

The Board of Directors of Kyung Dong Pharmaceutical Co., Ltd. has authorized a buyback plan on September 16, 2022.

Latest news about Kyung Dong Pharmaceutical Co., Ltd.

Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	May. 02	CI
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	May. 02	CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 200,000 shares, representing 0.74% for KRW 1,278.39 million.	Apr. 25	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 200,000 shares.	Jan. 30	CI
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	Jan. 29	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Kyung Dong Pharmaceutical Co., Ltd.(KOSDAQ:A011040) dropped from S&P Global BMI Index	23-09-18	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 16, 2022.	22-10-19	CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 16, 202, has closed with 100,000 shares, representing 0.37% for KRW 749.64 million.	22-10-12	CI
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 100,000 shares.	22-09-16	CI
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	22-09-15	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	22-04-12	MT
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-21	CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 17, 2021, has expired.	21-11-16	CI
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 300,000 shares.	21-08-17	CI
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	21-08-16	CI
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 10, 2021.	21-05-26	CI
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 10, 2021, has closed with 250,000 shares, representing 0.9% for KRW 2,671.22 million.	21-05-25	CI

Chart Kyung Dong Pharmaceutical Co., Ltd.

Duration

Period

Chart Kyung Dong Pharmaceutical Co., Ltd.

More charts

KYUNG DONG PHARMACEUTICAL CO.,LTD. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Companyâs products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. It also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
KYUNG DONG PHARMACEUTICAL CO., LTD.	-1.97%	130M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.63%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.99%	22.71B
SANDOZ GROUP AG	+18.22%	15.15B
CIPLA LIMITED	+12.66%	13.61B
ZYDUS LIFESCIENCES LIMITED	+60.18%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.35%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.92%	5.63B

Generic Pharmaceuticals